Intel

CVE-2026-14973

aspera: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CVE-2026-14973)

criticalEPSS 0.4%

Affected

  • ibm/aspera between 1.0.5..1.0.19

Description

IBM Aspera Desktop App 1.0.5 through 1.0.19 IBM Aspera for desktop can allow files to be written outside of the user's selected download destination.

Source: NVD (NIST)cvelistv5

Affected products

The following versions are affected. Older releases of the same product line are also vulnerable unless stated otherwise.

ibmaspera
1.0.5 – 1.0.19

Metrics

XIEM Effective CVSS
9.3
Source: nvd-v3
EPSS percentile
37.3 %
High — this CVE ranks above the median of all CVEs scored today (rank ≥ 36%).
KEV status
—
Show all metrics
Severity
critical
Priority score
81.10
Exploit maturity
no public PoC known
CVSS v3
9.3
EPSS score
0.4 %
Low — model estimates < 1% exploitation likelihood.
Published
2026-07-28 20:31 UTC
CWE
CWE-22

Weakness classes (CWE)

  • CWE-22Base

    Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

    The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

    cwe.mitre.org →

References & sources

Reanalysis & status changes

Chronological NVD audit events for this CVE — reanalyses, CVSS updates, CPE diffs.

  1. CVE Modified2026-07-29 14:16 UTC· 134c704f-9b21-4f2e-91b3-4a467353bcc0
    • SSVC: {"id":"CVE-2026-14973","role":"CISA Coordinator","options":[{"exploitation":"none"},{"automatable":"no"},{"technicalI…

Linked advisories